vs

Side-by-side financial comparison of agilon health, inc. (AGL) and EnerSys (ENS). Click either name above to swap in a different company.

agilon health, inc. is the larger business by last-quarter revenue ($1.6B vs $919.1M, roughly 1.7× EnerSys). EnerSys runs the higher net margin — 9.8% vs -12.0%, a 21.9% gap on every dollar of revenue. On growth, agilon health, inc. posted the faster year-over-year revenue change (3.1% vs 1.4%). EnerSys produced more free cash flow last quarter ($171.3M vs $-23.5M). Over the past eight quarters, EnerSys's revenue compounded faster (0.5% CAGR vs -1.1%).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.

AGL vs ENS — Head-to-Head

Bigger by revenue
AGL
AGL
1.7× larger
AGL
$1.6B
$919.1M
ENS
Growing faster (revenue YoY)
AGL
AGL
+1.7% gap
AGL
3.1%
1.4%
ENS
Higher net margin
ENS
ENS
21.9% more per $
ENS
9.8%
-12.0%
AGL
More free cash flow
ENS
ENS
$194.8M more FCF
ENS
$171.3M
$-23.5M
AGL
Faster 2-yr revenue CAGR
ENS
ENS
Annualised
ENS
0.5%
-1.1%
AGL

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
AGL
AGL
ENS
ENS
Revenue
$1.6B
$919.1M
Net Profit
$-188.9M
$90.4M
Gross Margin
30.1%
Operating Margin
-12.3%
13.5%
Net Margin
-12.0%
9.8%
Revenue YoY
3.1%
1.4%
Net Profit YoY
-78.5%
-21.3%
EPS (diluted)
$2.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
ENS
ENS
Q4 25
$1.6B
$919.1M
Q3 25
$1.4B
$951.3M
Q2 25
$1.4B
$893.0M
Q1 25
$1.5B
$974.8M
Q4 24
$1.5B
$906.2M
Q3 24
$1.5B
$883.7M
Q2 24
$1.5B
$852.9M
Q1 24
$1.6B
$910.7M
Net Profit
AGL
AGL
ENS
ENS
Q4 25
$-188.9M
$90.4M
Q3 25
$-110.2M
$68.4M
Q2 25
$-104.4M
$57.5M
Q1 25
$12.1M
$96.5M
Q4 24
$-105.8M
$114.8M
Q3 24
$-117.6M
$82.3M
Q2 24
$-30.7M
$70.1M
Q1 24
$-6.1M
$60.9M
Gross Margin
AGL
AGL
ENS
ENS
Q4 25
30.1%
Q3 25
29.1%
Q2 25
28.4%
Q1 25
31.2%
Q4 24
32.9%
Q3 24
28.5%
Q2 24
27.9%
Q1 24
27.9%
Operating Margin
AGL
AGL
ENS
ENS
Q4 25
-12.3%
13.5%
Q3 25
-9.1%
9.7%
Q2 25
-8.3%
9.7%
Q1 25
-1.4%
13.5%
Q4 24
-7.1%
15.7%
Q3 24
-9.2%
11.2%
Q2 24
-2.9%
10.7%
Q1 24
-0.4%
8.9%
Net Margin
AGL
AGL
ENS
ENS
Q4 25
-12.0%
9.8%
Q3 25
-7.7%
7.2%
Q2 25
-7.5%
6.4%
Q1 25
0.8%
9.9%
Q4 24
-6.9%
12.7%
Q3 24
-8.1%
9.3%
Q2 24
-2.1%
8.2%
Q1 24
-0.4%
6.7%
EPS (diluted)
AGL
AGL
ENS
ENS
Q4 25
$2.40
Q3 25
$1.80
Q2 25
$1.46
Q1 25
$2.39
Q4 24
$2.88
Q3 24
$2.01
Q2 24
$1.71
Q1 24
$1.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
ENS
ENS
Cash + ST InvestmentsLiquidity on hand
$173.7M
$450.1M
Total DebtLower is stronger
$35.0M
Stockholders' EquityBook value
$126.7M
$1.9B
Total Assets
$1.3B
$4.0B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
ENS
ENS
Q4 25
$173.7M
$450.1M
Q3 25
$171.7M
$388.6M
Q2 25
$171.4M
$346.7M
Q1 25
$136.9M
$343.1M
Q4 24
$188.2M
$463.2M
Q3 24
$148.2M
$407.9M
Q2 24
$109.5M
$344.1M
Q1 24
$111.7M
$333.3M
Total Debt
AGL
AGL
ENS
ENS
Q4 25
$35.0M
Q3 25
Q2 25
Q1 25
$1.1B
Q4 24
Q3 24
Q2 24
Q1 24
$802.0M
Stockholders' Equity
AGL
AGL
ENS
ENS
Q4 25
$126.7M
$1.9B
Q3 25
$306.1M
$1.9B
Q2 25
$408.9M
$1.9B
Q1 25
$500.3M
$1.9B
Q4 24
$471.0M
$1.8B
Q3 24
$574.9M
$1.8B
Q2 24
$676.6M
$1.8B
Q1 24
$689.3M
$1.8B
Total Assets
AGL
AGL
ENS
ENS
Q4 25
$1.3B
$4.0B
Q3 25
$1.6B
$4.1B
Q2 25
$1.7B
$4.1B
Q1 25
$1.9B
$4.0B
Q4 24
$1.7B
$4.0B
Q3 24
$2.1B
$4.0B
Q2 24
$2.2B
$3.6B
Q1 24
$2.3B
$3.5B
Debt / Equity
AGL
AGL
ENS
ENS
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
0.57×
Q4 24
Q3 24
Q2 24
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
ENS
ENS
Operating Cash FlowLast quarter
$-20.5M
$184.6M
Free Cash FlowOCF − Capex
$-23.5M
$171.3M
FCF MarginFCF / Revenue
-1.5%
18.6%
Capex IntensityCapex / Revenue
0.2%
1.4%
Cash ConversionOCF / Net Profit
2.04×
TTM Free Cash FlowTrailing 4 quarters
$-119.0M
$441.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
ENS
ENS
Q4 25
$-20.5M
$184.6M
Q3 25
$-18.2M
$218.0M
Q2 25
$-35.1M
$968.0K
Q1 25
$-32.0M
$135.2M
Q4 24
$16.4M
$81.1M
Q3 24
$-7.7M
$33.6M
Q2 24
$-18.7M
$10.4M
Q1 24
$-47.8M
Free Cash Flow
AGL
AGL
ENS
ENS
Q4 25
$-23.5M
$171.3M
Q3 25
$-21.3M
$197.1M
Q2 25
$-38.3M
$-32.1M
Q1 25
$-35.8M
$104.9M
Q4 24
$13.2M
$56.8M
Q3 24
$-11.2M
$3.3M
Q2 24
$-22.0M
$-25.7M
Q1 24
$-50.9M
FCF Margin
AGL
AGL
ENS
ENS
Q4 25
-1.5%
18.6%
Q3 25
-1.5%
20.7%
Q2 25
-2.7%
-3.6%
Q1 25
-2.3%
10.8%
Q4 24
0.9%
6.3%
Q3 24
-0.8%
0.4%
Q2 24
-1.5%
-3.0%
Q1 24
-3.2%
Capex Intensity
AGL
AGL
ENS
ENS
Q4 25
0.2%
1.4%
Q3 25
0.2%
2.2%
Q2 25
0.2%
3.7%
Q1 25
0.3%
3.1%
Q4 24
0.2%
2.7%
Q3 24
0.2%
3.4%
Q2 24
0.2%
4.2%
Q1 24
0.2%
Cash Conversion
AGL
AGL
ENS
ENS
Q4 25
2.04×
Q3 25
3.19×
Q2 25
0.02×
Q1 25
-2.64×
1.40×
Q4 24
0.71×
Q3 24
0.41×
Q2 24
0.15×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

ENS
ENS

Energy Systems$399.5M43%
Motive Power$352.0M38%
Services$92.6M10%
Transferred Over Time$38.2M4%
Other$36.8M4%

Related Comparisons